Michael Höpfner

Dr. Michael Höpfner

Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Physiology, Campus Charité Mitte, Charitéplatz 1, 10117 Berlin, German
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
OAOluwatosin Adekunle Adaramoye
Oluwatosin Adekunle Adaramoye
BEBettina Erguen
Bettina Erguen
BNBianca Nitzsche
Bianca Nitzsche
Michael HöpfnerMichael Höpfner
Michael Höpfner
KJKlaus Jung
Klaus Jung
ARAnja Rabien
Anja Rabien

1 March 2016 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
WKWeronika Kuzyniak
Weronika Kuzyniak
EEEugeny A. Ermilov
Eugeny A. Ermilov
DADevrim Atilla
Devrim Atilla
AGAyşe Gül Gürek
Ayşe Gül Gürek
BNBianca Nitzsche
Bianca Nitzsche
Michael HöpfnerMichael Höpfner
Michael Höpfner

15 June 2010 in British Journal of Cancer
Verified
Journal Article
Open access
BNB Nitzsche
B Nitzsche
CGC Gloesenkamp
C Gloesenkamp
MSM Schrader
M Schrader
MOM Ocker
M Ocker
RPRobert Preissner
Robert Preissner
Michael HöpfnerMichael Höpfner
Michael Höpfner
Backround: Results: Conclusion:

1 May 2014 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
WKWeronika Kuzyniak
Weronika Kuzyniak
OAOluwasesan Adegoke
Oluwasesan Adegoke
KSKutloano Sekhosana
Kutloano Sekhosana
SDSarah D'Souza
Sarah D'Souza
STSesethu Charmaine Tshangana
Sesethu Charmaine Tshangana
Michael HöpfnerMichael Höpfner
Michael Höpfner

1 October 2002
Verified
Journal Article
Closed access
KMKerstin Maaser
Kerstin Maaser
PGPatricia Grabowski
Patricia Grabowski
ASAndreas P Sutter
Andreas P Sutter
Michael HöpfnerMichael Höpfner
Michael Höpfner
HFHans-Dieter Foss
Hans-Dieter Foss
HSHans Scherübl
Hans Scherübl

27 January 2014 in Polymers
Verified
Journal Article
Open access
PDF file
VSVerena Schenk
Verena Schenk
ERElisabeth Rossegger
Elisabeth Rossegger
CEClemens Ebner
Clemens Ebner
FBFlorian Bangerl
Florian Bangerl
KRKlaus Reichmann
Klaus Reichmann
Frank WiesbrockFrank Wiesbrock
Frank Wiesbrock
Poly(2-oxazoline) networks with varying swelling degrees and varying hydrophilicity can be synthesized from 2-ethyl-2-oxazoline, 2-nonyl-2-oxazoline, 2-9’-decenyl-2-oxazoline and 2,2’-tetramethylene-bis-2-oxazoline in one-pot/one-step strategies. These gels can be loaded with organic molecules, such as fluorescein isothiocyanate, either during the polymerization (covalent attachment of the dye) or according to post-synthetic swelling/deswelling strategies (physical inclusion of the dye). Surface functionalization of ground gels by thiol-ene reactions with cysteine-bearing peptides exhibiting the arginine-glycine-aspartic acid (RGD) motif yields microparticles with enhanced recognition of human cancer cells compared to healthy endothelial cells.